Fibrilación auricular: comorbilidades, índice tromboembólico y estrategia terapéutica. Hospital de Especialidades José Carrasco Arteaga. 2017

Abstract

Introduction: Atrial fibrillation represents a serious health problem worldwide. It has been estimated that approximately 1.5-2% of the world population suffers from this arrhythmia. It has a great socioeconomic impact due to its high morbidity and mortality.

General objective: to determine the frequency of the main comorbidities of atrial fibrillation, the thromboembolic risk and the main therapeutic strategy in adult patients of the cardiology department of the Hospital "José Carrasco Arteaga" of the city of Cuenca.

Methodology: Descriptive and retrospective study with 297 clinical histories of patients diagnosed with atrial fibrillation, at the Hospital José Carrasco Arteaga, during the year 2017. The information was collected in an elaborated form by the authors, and analyzed with the programs PSPP Free Software Foundation, Epidat 4,1 and Excel 2016 through distributions frequency, percentages and average. The results are presented in relevant tables.

Results: The 52.5% of the population studied were men; non-valvular atrial fibrillation accounted for 82.5% of cases; the most frequent comorbiditie was arterial hypertension in 50.5% of the cases; thromboembolic risk was high in 77.1% of patients with non-valvular atrial fibrillation; anticoagulation was the therapeutic strategy in 67% of patients.

Conclusion: The distribution by sex was presented in similar proportions; arterial hypertension was the most frequent comorbidity; a high thromboembolic risk was determined in patients with non-valvular atrial fibrillation, the priority therapeutic strategy was anticoagulation.67.3% of patients.